News
GRFS
7.33
-3.55%
-0.27
Grifols debt placement contains clause for Brookfield, Bloomberg says
TipRanks · 2d ago
ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip?
NASDAQ · 4d ago
Grifols holder Flat Footed calls for ‘prompt governance overhaul’
TipRanks · 4d ago
Spanish stocks - Factors to watch on Dec 10
Reuters · 4d ago
Weekly Report: what happened at GRFS last week (1202-1206)?
Weekly Report · 5d ago
EUROPE RESEARCH ROUNDUP-Adyen, Berkeley, Iveco
Reuters · 5d ago
UPDATE 1-Spain's market regulator sees signs of manipulation in Grifols-Gotham dispute
Reuters · 12/05 12:29
Look Under The Hood: KOMP Has 14% Upside
NASDAQ · 12/05 12:28
SPANISH STOCK MARKET REGULATOR CHIEF: WE ARE CONVINCED THERE ARE SIGNS OF POSSIBLE MARKET MANIPULATION IN CASE OF GRIFOLS/GOTHAM
Reuters · 12/05 11:55
Grifols price target lowered to EUR 9.50 from EUR 14 at JPMorgan
TipRanks · 12/03 20:05
'Grifols Shareholder Mason Capital Calls For Board Overhaul' - Bloomberg News
Benzinga · 12/02 20:29
Weekly Report: what happened at GRFS last week (1125-1129)?
Weekly Report · 12/02 09:25
Key deals this week: EnLink Midstream, Peabody, StoneCo, UniCredit and more
Seeking Alpha · 11/30 18:45
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 11/29 21:06
Grifols: More Attractive Than In A Very Long Time
Seeking Alpha · 11/29 17:30
Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?
Benzinga · 11/29 14:29
Grifols said to be in talks to restructure debt
Seeking Alpha · 11/29 13:13
Grifols Stock Declines After Brookfield Drops Buyout Offer
Barchart · 11/28 10:10
Grifols Board Announces Termination Of Discussions With Brookfield - Quick Facts
NASDAQ · 11/28 08:19
Grifols to Outline Standalone Strategy After Brookfield Drops $6.8 Billion Bid
Dow Jones · 11/28 06:47
More
Webull provides a variety of real-time GRFS stock news. You can receive the latest news about Grifols S A through multiple platforms. This information may help you make smarter investment decisions.
About GRFS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.